UAB To Test Potential COVID-19 Vaccine
By BirminghamWatch
The University of Alabama at Birmingham and the biopharmaceutical company Altimmune Inc. will test a potential vaccine for COVID-19, the university announced today.
Testing of the vaccine, AdCOVID, which was developed by the company based in Gaithersburg, Maryland, will begin in mice during the second quarter of this year. That phase of testing, designed to show the immune response to the drug in mice, is expected to take one to two months, UAB said in announcing the collaboration.
The vaccine is given in a single dose of intranasal spray, UAB said. If results of the tests in mice warrant, Altimmune could launch a Phase 1 human safety trial during the third quarter of this year.
The announcement by UAB said Altimmune “has significant experience in the development of intranasal vaccine candidates for respiratory pathogens, including a seasonal and pandemic influenza vaccine and a vaccine for inhalation anthrax.”
“We are eager to collaborate with Altimmune on this important project,” said Frances E. Lund, the Charles H. McCauley Professor and Chair for the UAB Department of Microbiology. “The expertise and infrastructure at UAB will be invaluable to the rapid progression of this vaccine into clinical studies.
Lund said six labs at UAB will work on the project.
Vipin K. Garg, president and CEO of Altimmune, cited UAB’s role in research in virology and immunology. He said the company was founded through a technology license from UAB in 1997.
“It is critical that the biotechnology industry and academic institutions work together to prevent the further spread of COVID-19, and UAB is an ideal partner to support us in this effort,”Garg said.
UAB also has extensive experience in conducting clinical studies of vaccines and has participated in studies sponsored by the Vaccine Evaluation and Trial Unit, part of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health.
The vaccine being tested “will activate mucosal and cellular immune responses, as well as a strong antibody response in the blood,” the announcement said.
“If the AdCOVID vaccine candidate is as stable as Altimmune’s influenza and anthrax vaccines candidates, that may allow inexpensive and efficient distribution of the millions of doses needed for widespread vaccination of populations,” the statement said.
40 years after ‘Purple Rain,’ Prince’s band remembers how the movie came together
Before social media, the film Purple Rain gave audiences a peak into Prince’s musical life. Band members say the true genesis of the title song was much less combative than the version presented in the film.
Park Fire in California could continue growing exponentially, Cal Fire officer says
Cal Fire has confirmed that over a hundred structures have been damaged in the Park Fire, which grew overnight near Chico, Calif. Difficult firefighting conditions are forecast through Friday night.
Checking in with Black voters in Georgia about the election, now that Biden is out
Some voters who could be key to deciding who wins Georgia. What do they think about Vice President Harris becoming the frontrunner in the race to be the Democratic nominee?
Tahiti’s waves are a matter of ‘life and death’ for surfing Olympics
Tahiti's Teahupo'o wave has a slew of riders for the Paris 2024 Olympics. NPR finds out why it's called one of the most dangerous waves.
Researchers are revising botanical names to address troubling connotations
Since the mid-1700s, researchers have classified life with scientific names. But some of them have problematic histories and connotations. The botanical community is trying to tackle this issue.
A spectacular opening ceremony wowed a global audience despite Paris’ on-and-off rain
The Paris Olympics opening ceremony wowed Parisians, fans and most everyone who was able to catch a glimpse of thousands of athletes floating down the Seine to officially begin the Games.
